Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Announcing a New Article Type in <i>JCO Clinical Cancer Informatics</i>: The Resource Report.

JCO clinical cancer informatics·2026

Same author

ceQTL: a co-expression QTL model to detect a variant that affects transcription factor binding and its target regulation.

Briefings in bioinformatics·2026

Same author

Persistently Higher Ratio of Gallbladder Cancer Incidence in Native American People than in Non-Hispanic Whites: Selected United States Regions, 1962-2021.

Journal of racial and ethnic health disparities·2026

Same author

Trends in design of FDA registrational randomized clinical trials in hematology and oncology: a 20-year cohort study.

BMJ connections. Oncology·2026

Same author

Extraction of Treatments and Responses From Non-Small Cell Lung Cancer Clinical Notes Using Natural Language Processing.

JCO clinical cancer informatics·2026

Same author

Systemic Anticancer Therapy Timelines Extraction From Electronic Medical Records Text: Algorithm Development and Validation.

JMIR bioinformatics and biotechnology·2025

Search research articles

Related Experiment Video

Updated: Jun 23, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Extracting Systemic Anticancer Therapy and Response Information From Clinical Notes Following the RECIST Definition.

Xu Zuo¹, Ashok Kumar², Shuhan Shen²

¹University of Texas Health Science Center, Houston, TX.

JCO Clinical Cancer Informatics

|June 17, 2024

Summary

This summary is machine-generated.

This study introduces a natural language processing (NLP) system to automate the extraction of cancer treatment and response data from clinical notes. This approach enhances the efficiency and reliability of evaluating anticancer therapy effectiveness.

More Related Videos

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Related Experiment Videos

Last Updated: Jun 23, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Area of Science:

Oncology
Medical Informatics
Computational Linguistics

Background:

Manual RECIST (Response Evaluation Criteria In Solid Tumors) data extraction from clinical notes is labor-intensive.
Standardized RECIST evaluation is crucial for comparing cancer treatment efficacy.
Electronic health records contain complex clinical notes, hindering manual data collection.

Purpose of the Study:

To develop and apply natural language processing (NLP) techniques to automate RECIST data extraction.
To minimize manual data collection efforts for cancer treatment response assessment.
To improve the consistency and reliability of RECIST evaluations.

Main Methods:

A hybrid NLP system combining machine learning, deep learning, and rule-based modules was developed.
The system performs named entity recognition, assertion classification, relation extraction, and text normalization.
Domain-specific language models (BioBERT, BioClinicalBERT) were utilized for therapy and response extraction.

Main Results:

The NLP system successfully extracted, linked, and summarized anticancer therapy and RECIST-like responses.
The best model achieved a 0.66 score for linking therapy and RECIST mentions.
End-to-end performance reached 0.74 after relation normalization, demonstrating significant efficacy.

Conclusions:

An automated information extraction system for cancer treatment and efficacy data from clinical notes was developed and tested.
The system is expected to support future oncologic research by improving the assessment of cancer therapeutics.
This NLP approach offers a more efficient and reliable method for evaluating treatment effectiveness.